Rachel A. Woolaver

Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts

Rachel A. Woolaver, Xiaoguang Wang, Alexandra L. Krinsky et al. · Journal for ImmunoTherapy of Cancer · 2021 · 36 citations · Full text

Medicine, Immunology, Oncology +17

MHC class I-independent activation of virtual memory CD8 T cells induced by chemotherapeutic agent-treated cancer cells

Xiaoguang Wang, Brittany C. Waschke, Rachel A. Woolaver et al. · Cellular and Molecular Immunology · 2020 · 30 citations · Full text

Life Sciences, Immunology, Oncology +16

TRAF3 Acts as a Checkpoint of B Cell Receptor Signaling to Control Antibody Class Switch Recombination and Anergy

Zhangguo Chen, Alexandra L. Krinsky, Rachel A. Woolaver et al. · The Journal of Immunology · 2020 · 25 citations · Full text

Life Sciences, Immunology, Pathology +17

Distinct immune microenvironment profiles of therapeutic responders emerge in combined TGFβ/PD-L1 blockade-treated squamous cell carcinoma

Alexander A. Strait, Rachel A. Woolaver, Spencer C. Hall et al. · Communications Biology · 2021 · 21 citations · Full text

Medicine, Immunology, Oncology +17

Differential responses to immune checkpoint inhibitor dictated by pre-existing differential immune profiles in squamous cell carcinomas caused by same initial oncogenic drivers

Samantha M. Y. Chen, Vince Popolizio, Rachel A. Woolaver et al. · Journal of Experimental & Clinical Cancer Research · 2022 · 20 citations · Full text

Life Sciences, Immunology, Oncology +17